Cargando…
Recombinant vaccine containing an RBD-Fc fusion induced protection against SARS-CoV-2 in nonhuman primates and mice
Autores principales: | Sun, Shihui, He, Lei, Zhao, Zhongpeng, Gu, Hongjing, Fang, Xin, Wang, Tiecheng, Yang, Xiaolan, Chen, Shaolong, Deng, Yongqiang, Li, Jiangfan, Zhao, Jian, Li, Liang, Li, Xinwang, He, Peng, Li, Ge, Li, Hao, Zhao, Yuee, Gao, Chunrun, Lang, Xiaoling, Wang, Xin, Fei, Guoqiang, Li, Yan, Geng, Shusheng, Gao, Yuwei, Wei, Wenjin, Hu, Zhongyu, Han, Gencheng, Sun, Yansong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7966917/ https://www.ncbi.nlm.nih.gov/pubmed/33731916 http://dx.doi.org/10.1038/s41423-021-00658-z |
Ejemplares similares
-
A randomized, double‐blind, placebo‐controlled phase 1 and phase 2 clinical trial to evaluate efficacy and safety of a SARS‐CoV‐2 vaccine SCoK in adults
por: Luo, Deyan, et al.
Publicado: (2022) -
Adaptation of SARS-CoV-2 in BALB/c mice for testing vaccine efficacy
por: Gu, Hongjing, et al.
Publicado: (2020) -
Long-term stability and protection efficacy of the RBD-targeting COVID-19 mRNA vaccine in nonhuman primates
por: Zhao, Hui, et al.
Publicado: (2021) -
An updated RBD-Fc fusion vaccine booster increases neutralization of SARS-CoV-2 Omicron variants
por: Luo, Deyan, et al.
Publicado: (2022) -
Neutralization of BQ.1, BQ.1.1, and XBB with RBD-Dimer Vaccines
por: Li, Dedong, et al.
Publicado: (2023)